267 related articles for article (PubMed ID: 14634018)
1. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity.
Watabe H; Valencia JC; Yasumoto K; Kushimoto T; Ando H; Muller J; Vieira WD; Mizoguchi M; Appella E; Hearing VJ
J Biol Chem; 2004 Feb; 279(9):7971-81. PubMed ID: 14634018
[TBL] [Abstract][Full Text] [Related]
2. Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo.
Kobayashi T; Hearing VJ
J Cell Sci; 2007 Dec; 120(Pt 24):4261-8. PubMed ID: 18042623
[TBL] [Abstract][Full Text] [Related]
3. Increased level of p27 subunit of proteasomes and its co-localization with tyrosinase in amelanotic melanoma cells indicate its direct role in the regulation of melanin biosynthesis.
Godbole D; Mojamdar M; Pal JK
Cell Biol Int; 2006 Nov; 30(11):895-902. PubMed ID: 16879986
[TBL] [Abstract][Full Text] [Related]
4. Membrane transport proteins in melanosomes: Regulation of ions for pigmentation.
Wiriyasermkul P; Moriyama S; Nagamori S
Biochim Biophys Acta Biomembr; 2020 Dec; 1862(12):183318. PubMed ID: 32333855
[TBL] [Abstract][Full Text] [Related]
5. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
[TBL] [Abstract][Full Text] [Related]
6. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.
Toyofuku K; Wada I; Spritz RA; Hearing VJ
Biochem J; 2001 Apr; 355(Pt 2):259-69. PubMed ID: 11284711
[TBL] [Abstract][Full Text] [Related]
8. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
[TBL] [Abstract][Full Text] [Related]
9. Heterologous expression of tyrosinase recapitulates the misprocessing and mistrafficking in oculocutaneous albinism type 2: effects of altering intracellular pH and pink-eyed dilution gene expression.
Ni-Komatsu L; Orlow SJ
Exp Eye Res; 2006 Mar; 82(3):519-28. PubMed ID: 16199032
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.
Halaban R; Svedine S; Cheng E; Smicun Y; Aron R; Hebert DN
Proc Natl Acad Sci U S A; 2000 May; 97(11):5889-94. PubMed ID: 10823941
[TBL] [Abstract][Full Text] [Related]
11. Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells.
Ancans J; Tobin DJ; Hoogduijn MJ; Smit NP; Wakamatsu K; Thody AJ
Exp Cell Res; 2001 Aug; 268(1):26-35. PubMed ID: 11461115
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a synchronized tyrosinase transport system revealed a role of Tyrp1 in efficient melanogenesis by promoting tyrosinase targeting to melanosomes.
Nakamura H; Fukuda M
Sci Rep; 2024 Jan; 14(1):2529. PubMed ID: 38291221
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of melanogenesis by phospholipase D2 through ubiquitin proteasome-mediated degradation of tyrosinase.
Kageyama A; Oka M; Okada T; Nakamura S; Ueyama T; Saito N; Hearing VJ; Ichihashi M; Nishigori C
J Biol Chem; 2004 Jun; 279(26):27774-80. PubMed ID: 15067002
[TBL] [Abstract][Full Text] [Related]
14. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
[TBL] [Abstract][Full Text] [Related]
15. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors.
Mishima Y
Pigment Cell Res; 1994 Dec; 7(6):376-87. PubMed ID: 7761345
[TBL] [Abstract][Full Text] [Related]
16. Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activity.
Di Domenico F; Foppoli C; Blarzino C; Perluigi M; Paolini F; Morici S; Coccia R; Cini C; De Marco F
J Exp Clin Cancer Res; 2009 Jan; 28(1):4. PubMed ID: 19133143
[TBL] [Abstract][Full Text] [Related]
17. Inulavosin, a melanogenesis inhibitor, leads to mistargeting of tyrosinase to lysosomes and accelerates its degradation.
Fujita H; Motokawa T; Katagiri T; Yokota S; Yamamoto A; Himeno M; Tanaka Y
J Invest Dermatol; 2009 Jun; 129(6):1489-99. PubMed ID: 19110539
[TBL] [Abstract][Full Text] [Related]
18. Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase.
Ando H; Kondoh H; Ichihashi M; Hearing VJ
J Invest Dermatol; 2007 Apr; 127(4):751-61. PubMed ID: 17218941
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the number of melanosomes, tyrosinase mRNA levels, and tyrosinase activity in cultured murine melanoma cells in response to various melanogenesis regulatory agents.
Ando H; Itoh A; Mishima Y; Ichihashi M
J Cell Physiol; 1995 Jun; 163(3):608-14. PubMed ID: 7775602
[TBL] [Abstract][Full Text] [Related]
20. Activation of melanogenesis by vacuolar type H(+)-ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma cells.
Ancans J; Thody AJ
FEBS Lett; 2000 Jul; 478(1-2):57-60. PubMed ID: 10922469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
